Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Programmed cell-death-1-ligand-1 inhibitors/programmed cell-death-1-receptor antagonists

Muscular-disorders, myocarditis and respiratory-failure: 9 case reports

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Matas-Garcia A, et al. Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern. Autoimmunity Reviews 19: No. 2, Feb 2020. Available from: URL: http://doi.org/10.1016/j.autrev.2019.102455

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Programmed cell-death-1-ligand-1 inhibitors/programmed cell-death-1-receptor antagonists. Reactions Weekly 1791, 221 (2020). https://doi.org/10.1007/s40278-020-75066-4

    Download citation